TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $225,000 | -24.0% | 4,500 | -3.2% | 0.00% | 0.0% |
| Q3 2021 | $296,000 | -8.6% | 4,650 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $324,000 | -2.4% | 4,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $332,000 | +0.6% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $330,000 | +33.6% | 4,500 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $247,000 | -17.4% | 4,500 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $299,000 | +8.7% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $275,000 | -30.6% | 4,500 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $396,000 | +16.5% | 4,500 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $340,000 | -11.5% | 4,500 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $384,000 | -30.7% | 4,500 | -12.2% | 0.00% | -40.0% |
| Q1 2019 | $554,000 | +27.6% | 5,128 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $434,000 | -13.9% | 5,128 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $504,000 | -20.1% | 5,128 | -6.0% | 0.00% | -33.3% |
| Q2 2018 | $631,000 | +12.3% | 5,455 | -4.2% | 0.01% | 0.0% |
| Q1 2018 | $562,000 | -33.9% | 5,693 | -29.8% | 0.01% | -33.3% |
| Q4 2017 | $850,000 | -4.5% | 8,114 | +2.7% | 0.01% | -10.0% |
| Q3 2017 | $890,000 | -10.5% | 7,898 | -11.0% | 0.01% | -16.7% |
| Q2 2017 | $994,000 | +10.3% | 8,870 | +14.9% | 0.01% | 0.0% |
| Q1 2017 | $901,000 | +47.0% | 7,722 | +32.7% | 0.01% | +33.3% |
| Q4 2016 | $613,000 | -1.0% | 5,820 | +3.9% | 0.01% | -18.2% |
| Q3 2016 | $619,000 | -22.8% | 5,600 | 0.0% | 0.01% | -47.6% |
| Q1 2016 | $802,000 | -7.3% | 5,600 | 0.0% | 0.02% | -4.5% |
| Q4 2015 | $865,000 | +34.5% | 5,600 | +24.4% | 0.02% | +22.2% |
| Q3 2015 | $643,000 | -99.9% | 4,500 | 0.0% | 0.02% | +28.6% |
| Q2 2015 | $646,605,000 | +101727.6% | 4,500 | 0.0% | 0.01% | +16.7% |
| Q1 2015 | $635,000 | -99.9% | 4,500 | 0.0% | 0.01% | -7.7% |
| Q4 2014 | $666,855,000 | -3.7% | 4,500 | 0.0% | 0.01% | -7.1% |
| Q3 2014 | $692,370,000 | +9.7% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $631,080,000 | +26.3% | 4,500 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $499,500,000 | -22.3% | 4,500 | -30.8% | 0.01% | -29.4% |
| Q4 2013 | $642,850,000 | +25.3% | 6,500 | -3.7% | 0.02% | +13.3% |
| Q3 2013 | $513,000,000 | – | 6,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |